XT
CALA

XTX Topco’s Calithera Biosciences, Inc CALA Stock Holding History

XTX Topco’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-917
Closed -$40K – 1095
2021
Q3 		$40K Sell
917
-645
-41% -$27.8K 0.01% 616
2021
Q2 		$65K Sell
1,562
-658
-30% -$28.9K 0.02% 708
2021
Q1 		$107K Buy
+2,220
New +$129K 0.05% 559

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

XTX Topco's CALA Position: Q4 2021 in Review

XTX Topco sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 917 shares — an estimated $40K sold.

XTX Topco first reported a position in CALA in Q1 2021 and held it in 3 quarters. The position peaked at $107K in Q1 2021. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • XTX Topco reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • XTX Topco sold 917 Calithera Biosciences, Inc shares in Q4 2021, an estimated $40K.
  • XTX Topco first reported a position in Calithera Biosciences, Inc in Q1 2021 and held it in 3 quarters.
  • XTX Topco's Calithera Biosciences, Inc position peaked at $107K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on XTX Topco's 13F filing for Q4 2021, filed 11 Feb 2022.